Text Size
57 studies found for:    Acetylcholinesterase

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: EHT 0202 etazolate;   Drug: Placebo
2 Recruiting Treatment With Acetyl-Choline Esterase Inhibitors in Children With Autism Spectrum Disorders
Condition: Autism
Interventions: Drug: Acetyl-Choline Esterase Inhibitors and Choline supplements;   Drug: Indistinguishable placebo tablets, matching both donepezil and choline
3 Active, not recruiting Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor
Conditions: Alzheimer's Disease;   Sleep Disorder
Interventions: Drug: Circadin;   Drug: Placebo
4 Recruiting Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Donepezil
5 Recruiting Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
Condition: Alzheimer's Disease
Interventions: Drug: ABT-126;   Drug: placebo
6 Completed Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke
Condition: Cerebrovascular Accident
Interventions: Drug: Galantamine;   Drug: Donepezil
7 Recruiting Rivastigmine in the Management of Delirium
Condition: Delirium
Interventions: Drug: Rivastigmine transdermal patch;   Drug: placebo patch
8 Completed A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ABT-126;   Drug: Placebo
9 Recruiting Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: ABT-126
10 Terminated Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237;   Drug: Placebo
11 Completed To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.
Condition: Alzheimer's Disease
Intervention: Drug: Atorvastatin
12 Terminated Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
Conditions: Alzheimer's Disease;   Mild-to-moderate Alzheimers Disease
Intervention: Drug: Rosiglitazone XR
13 Terminated Mifepristone as Adjunctive Therapy in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Mifepristone
14 Completed Use of Different Treatment Care Methods in Patients With Dementia Associated With Alzheimer's Disease
Conditions: Dementia;   Alzheimer's Disease
Intervention: Other: No intervention
15 Completed Effect of Donepexil on Smoking
Condition: Smoking
Intervention: Drug: Donepezil
16 Active, not recruiting Effect of Galantamine on Smoking Abstinence
Condition: Nicotine Addiction
Intervention: Drug: Galantamine ER
17 Unknown † Micro Ribonucleic Acid (RNA) as Cholinergic Tone and Inflammatory Regulator in Inflammatory Bowel Disease
Condition: Inflammatory Bowel Disease
Intervention:
18 Terminated Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ABT-089;   Drug: placebo
19 Completed Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rosiglitazone Extended Release 2mg;   Drug: Rosiglitazone Extended Release 8mg;   Other: Placebo
20 Recruiting MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Donepezil or Rivastigmine Therapy
Condition: Alzheimer Disease
Interventions: Drug: RO4602522;   Drug: RO4601522;   Drug: placebo;   Drug: donepezil;   Drug: rivastigmine
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years